Ovarian Cancer News

News

New results from a trial testing the Galleri blood test have reignited the conversation about whether a simple blood test could transform early cancer detection, but what does this mean for ovarian cancer?

News

For the first time ever, a new type of treatment called immunotherapy has been shown to help women with platinum-resistant ovarian cancer live longer.

News

Over the last three years, a number of high-profile American law-suits have been made against talcum powder manufacturer Johnson & Johnson, claiming talc use caused women to develop ovarian cancer. But is there any truth to the claims?

News

University College London Hospitals (UCLH) has introduced a new ovarian cancer surveillance service for women with BRCA1 and BRCA2 gene mutations, using the ROCA test.

News

Ovarian Cancer Action strongly welcomes today’s announcement of Jess’s Rule, a new NHS initiative that urges GPs to act if a patient has attended three times with the same unresolved symptoms.

News

Today, the Scottish Medicines Consortium (SMC) has announced they've approved rucaparib for the treatment of advanced (stage 3 or 4) grade epithelial ovarian, fallopian tube or primary peritoneal cancer.

News

Ovarian Cancer Action are proud to have added our name to a new joint statement championing better inclusion of older people in health and care research, led by the National Institute for Health and Care Research (NIHR).

News

We’re excited to announce that Ovarian Cancer Action is increasing our investment in the groundbreaking OvarianVax project to help bring this world-first ovarian cancer prevention vaccine closer to reality.

News

From July 2025, the cervical screening programme in England will be changing. Women and people with a cervix aged 25 to 64 will now be invited for routine cervical screening every five years – an increase from the current three-year interval for those under 50.

News

A recent storyline on BBC Casualty has taken a bold and important turn, focusing on ovarian cancer, a disease that often goes undetected until it's advanced. We're proud to be part of the team helping make sure Stevie’s journey was portrayed with accuracy, empathy and impact.

News

We’re proud to announce something that could be truly transformational in the lives of women with ovarian cancer: a $1 million global grant - powered by a game-changing collaboration with leading ovarian cancer research charities worldwide.

News

The latest decision from NICE gives access to this drug at an earlier stage for eligible women. This means they can begin taking this maintenance drug straight after their first-line chemotherapy, rather than waiting to see if the disease comes back.

News

This March, we’re raising awareness of a deeply concerning fact: 1 year survival rates in ovarian cancer have barely improved  in the last 10 years. While we want to highlight  this lack of progress, our supporters will know this isn’t the whole story.

News

The Kennel Club has announced the five finalists for its prestigious Hero Dog of the Year Award at Crufts, and among them is Louis, the incredible English Sett…

News

Ovarian Cancer Action, the UK’s leading ovarian cancer research charity, has appointed Claire Gillis, Global CEO of VML Health, as its new Chair of the Board.

News

The festive season is a time for reflection and gratitude. This year, we have even more to be thankful for, thanks to your unwavering support. Take a look at the progress you supported with your donations.

News

Following the Government’s call for ideas, Ovarian Cancer Action submitted its vision for the next 10 years of the NHS to improve survival rates for women with ovarian cancer. Learn more about our submission and why we think the next ten years can be transformative.

News

After nearly a decade of campaigning, Ovarian Cancer Action reviews the findings in the government-funded National Ovarian Cancer Audit. This milestone follows their groundbreaking feasibility pilot, which highlighted urgent inequalities in diagnosis and treatment. Learn how supporter action and advocacy helped make this audit a reality.

News

Discover how Ovarian Cancer Action’s 2019 HHMT Forum helped spark groundbreaking ovarian cancer immunotherapy research, leading to a promising vaccine now funded by Cancer Research UK. See how global collaboration is driving progress.

News

Our Research Grants and Impacts Manager, talks us through a patient involvement workshop held with Professor Ahmed whilst he was developing his research on ovarian cancer vaccines and why the patient voice is crucial to pushing key research forward.